Position in ARGX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$52,284,439
-$23,781,170 QoQ
Shares Held
71,598
-20.8% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,158,535,680 across 116 Biotechnology names. ARGX ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
This page
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in ARGX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,284,439 | 71,598 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $76,065,609 | 90,452 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $71,072,019 | 96,361 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $51,448,669 | 93,336 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $27,197,380 | 45,952 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $24,700,860 | 40,164 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $22,606,904 | 41,704 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18,150,698 | 42,207 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $18,075,291 | 45,909 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,107,113 | 23,939 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,597,060 | 23,589 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,253,359 | 23,743 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,846,166 | 23,743 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,994,560 | 23,743 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,382,466 | 23,743 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,691,642 | 20,301 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,428,061 | 17,215 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,485,518 | 18,520 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,845,746 | 9,423 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,583,180 | 8,580 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,362,846 | 8,580 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,650,927 | 9,014 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,677,380 | 14,008 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,851,862 | 12,662 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,919,306 | 14,570 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||